- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06707454
Postoperative Clinical and Neurophysiological Assessment of Patients After Open Heart Surgery
Study Overview
Status
Intervention / Treatment
Detailed Description
Coronary artery bypass grafting (CABAG) is one of the most common major surgical procedures, as more than 800,000 patients worldwide undergo myocardial revascularization procedures every year. Cardiopulmonary bypass (CPB) is an extracorporeal circulation procedure that assists the operation of cardiac and great vessels and is associated with perioperative morbidity and mortality.
Preoperative neurophysiological status as measured by electroencephalogram (EEG) had a specificity of 94.7% and a sensitivity of 76.9% for predicting 1-week postoperative cognitive status and with specificity of 78.3% and a sensitivity of 77.8% for predicting 3-months postoperative cognitive status.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Osama A Ebrahim, Master
- Phone Number: 00201016386372
- Email: osamaallam@med.asu.edu.eg
Study Locations
-
-
-
Cairo, Egypt, 11591
- Recruiting
- Ain Shams University
-
Contact:
- Osama A Ebrahim, Master
- Phone Number: 00201016386372
- Email: osamaallam@med.asu.edu.eg
-
Sub-Investigator:
- Mahmoud H EL Rakawy, MD
-
Sub-Investigator:
- Naglaa M EL Khayat, MD
-
Sub-Investigator:
- Ahmed A Gaber, MD
-
Sub-Investigator:
- Yousry A Abdelhamid, MD
-
Sub-Investigator:
- Adel M ELansary, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient ≥ 60 years.
- Both sexes.
- Patients who are scheduled for on-pump open heart surgery either isolated coronary artery bypass grafting (CABG) or combined CABG and valve surgery.
Exclusion Criteria:
- Patients with a past history of CNS disease (e.g. Epilepsy, brain tumors, or Dementia).
- Patients with metabolic disturbance.
- Illiterate patient.
- Patient with sever cognitive impairment on Mini-mental state Examination (MMSE) and/or Montreal Cognitive Assessment (MoCA)
- Patients who cannot undergo DEEG recordings (eg, uncooperative).
- Patients with abnormal brain images except for small vessel disease.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study group
Patients who will undergo open heart surgery, such as isolated coronary artery bypass grafting (CABG) or combined CABG and valve surgery.
|
The enrolled patients will undergo Digital Electroencephalography (DEEG) monitoring for at least two hours.
A senior epileptologist will make a DEEG interpretation to detect DEEG abnormality.
DEEG patterns will be categorized according to the American Clinical Neurophysiology Society's standardized critical care DEEG terminology(normal, slowing and asymmetry, sharp and wave, periodic discharges, ictal patterns burst suppression, and electrocerebral silence)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurological complications
Time Frame: 4 months postoperatively
|
Neurological complications, including nonconvulsive seizures after open heart surgery, will be recorded.
|
4 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Electroencephalography (DEEG) monitoring
Time Frame: 24 hours postoperatively
|
The enrolled patients will undergo Digital Electroencephalography (DEEG) monitoring for at least two hours.
A senior epileptologist will interpret the DEEG to detect abnormalities.
The DEEG patterns will be categorized according to the American Clinical Neurophysiology Society's standardized critical care DEEG terminology(normal, slowing and asymmetry, sharp and wave, periodic discharges, ictal patterns burst suppression, and electrocerebral silence).
|
24 hours postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FMASU MD115/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.